ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,116.17
      0.32%
      US Tech 100
      17,294.00
      -0.09%
      Dow Jones
      38,386.09
      0.38%
      Brent Oil
      87.48
      0.22%
      Bitcoin
      61,940.59
      -2.97%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Novan Inc (NOVN)

      7. Novan Inc (NOVN) News

      NOVN

      Novan (NOVN)

      Novan Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NOVN
      DateTimeSourceHeadlineSymbolCompany
      03/25/20248:54AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      02/26/20244:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      01/30/20244:47PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      01/26/20244:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      01/05/20249:23AMGlobeNewswire Inc.Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in IndianapolisNASDAQ:NOVNNovan Inc
      12/21/20234:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      12/10/20237:30PMGlobeNewswire Inc.Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)NASDAQ:NOVNNovan Inc
      12/08/20239:15AMGlobeNewswire Inc.Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissionsNASDAQ:NOVNNovan Inc
      12/05/20237:16PMGlobeNewswire Inc.Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNHNASDAQ:NOVNNovan Inc
      11/20/20231:15AMGlobeNewswire Inc.Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNASDAQ:NOVNNovan Inc
      10/24/20235:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      10/20/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      09/07/20234:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      08/24/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      07/26/20234:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      07/17/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      07/17/20239:23AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      07/17/20238:45AMGlobeNewswire Inc.Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 ProtectionNASDAQ:NOVNNovan Inc
      07/06/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
      06/27/20236:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NOVNNovan Inc
      06/16/20235:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
      06/12/20239:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
      06/05/20239:00AMGlobeNewswire Inc.Novan to Provide Corporate Update at its 2023 Annual Meeting of StockholdersNASDAQ:NOVNNovan Inc
      05/31/20234:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
      05/31/20234:05PMGlobeNewswire Inc.Novan Focuses Strategic Direction and Announces RestructuringNASDAQ:NOVNNovan Inc
      05/15/20236:56AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NOVNNovan Inc
      05/15/20236:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
      05/15/20236:45AMGlobeNewswire Inc.Novan Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:NOVNNovan Inc
      05/08/20239:05AMGlobeNewswire Inc.Novan to Report First Quarter 2023 Financial Results on May 15, 2023NASDAQ:NOVNNovan Inc
      04/27/20239:10AMGlobeNewswire Inc.Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹NASDAQ:NOVNNovan Inc
       Showing the most relevant articles for your search:NASDAQ:NOVN